Screener
Bristol-Myers Squibb BMY Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's net debt?
- Bristol-Myers Squibb (BMY) reported net debt of $34.61B in Q2 2026.
- How has Bristol-Myers Squibb's net debt changed year-over-year?
- Bristol-Myers Squibb's net debt decreased by 5.9% year-over-year, from $36.78B to $34.61B.
- What is the long-term trend for Bristol-Myers Squibb's net debt?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's net debt has grown at a 0.0% compound annual growth rate (CAGR), from $36.88B to $36.93B.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Bristol-Myers Squibb's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude